Do people with asthma have higher levels of stress than people without asthma?

By: Shahid Mukhtar 

 The research about the role of stress or stress hormones on asthma is ongoing. Many things discovered showed that stress triggers asthma in humans. A researched model is highlighting the basic mechanism behind stress and asthma. The basic premise of this model is that depression works by altering the magnitude of the respiratory tract response that is triggered by irritants, allergies, and diseases that are transmitted to people with asthma. It is important to note that the model suggests that pressure alone cannot alter immune function in a way that leads to asthma symptoms. Rather, stress is considered to be a process that emphasizes the inflammatory response of airways to environmental factors and, in so doing, increases the frequency, duration, and severity of patient symptoms. Various internal and external factors have been identified that contribute to the increase in asthma. For example, exposure to secondhand smoke can lead to asthma and asthma symptoms in vulnerable people, as well as infections in the upper and lower respiratory tract. In intelligent people, exposure to allergies, such as cat dander and fungus, can cause an overactive bronchial reaction. One of the most common causes of these causes is inflammation of the airways. When it enters the body, for example, inhaled allergies are taken up by dendritic cells, and introduced into T helper (Th) cells. There are two phenotypes of cells,, known as Th-1 and Th-2. Th-1 cells normally initiate and coordinate immune responses by releasing cytokines such as IL-2 and IFN-g. In contrast, Th-2 cells promote B cell proliferation and differentiation, leading to a humorous response that involves antibody synthesis. They do this by releasing cytokines such as IL-4, IL-5, & IL-13. It is one of those moody times where he would break into endless soliloquies with himself. The cytokines of Th-2 IL-4 and IL-13 act by binding to B cells, and stimulate them to bind and release IgE antibodies. IgE then binds to mast cells that live on airways. When IgE molecules bind to their cognate allergen, it causes the mast cell to collapse, leading to the release of diseased mediators such as histamine and leukotrienes. Histamines and leukotrienes cause constipation, smooth muscle contraction, and mucus, leading to asthma clinical manifestations including shortness of breath, chest tightness, and shortness of breath. This method involves the first response. The longest phase reaction is produced when Th2 cells release IL-5. This cytokine accumulates eosinophils in the airways, where it causes inflammation and blockage. Eosinophils also release mediators, such as eosinophil cationic protein and a large basic protein, which can cause damage to air cells, as well as leukotrienes, causing edema and bronchial congestion. Therefore, this late-phase response makes clinical symptoms worse by promoting inflammation and obstruction of the airway.

Research on Students with Asthma

A number of research projects have specifically examined whether stress enhances the immune response to asthma. One group studied college students with asthma during periods of major depression (final exam time) and low stress (no major exams). At each visit, patients inhaled the increasing amounts of allergies they had been exposed to (ragweed, cat, or dust mites) until their lung function decreased by ≥20%. There has been evidence of a strong immune response to the challenge under stressful conditions. During a session that took place near the final tests, an allergy challenge triggered large amounts of eosinophils in both sputum and blood. A similar discovery of the in vitro production of IL-5 in phlegm treated with phytohemagglutinin emerged. These findings provide direct support for the basic model of our model - that stress enhances the immune response to natural asthma attacks. It does this by force, using an in vivo exposure paradigm, and collects samples from both sputum and peripheral blood.

In a series of studies from one study group, high school students were screened before the test (baseline for depression) and after the tests (period of major depression), and their nearby blood cells were in vitro stimulated with various mitogen cocktails. In another study, students with asthma had a higher IL-5 post-exam production compared to healthy students. In contrast, there was no group difference in IL-5 production at baseline. This suggests that under conditions of low stress, people with asthma are not different from healthy people in their response to mitogens, but that stress periods increase the Th-2 cellular response to mitogens, especially in people with asthma. A second study from this group showed that experimental stress was associated with reduced production of Th-1 cytokines IFN-g and IL-2, but increased production of pro-inflammatory cytokine IL-6 (which the group objected to representing Th) - 2) in both samples of asthma students and healthy students.

Finally, in one study of 2-year-old children with a family history of asthma or allergies, regenerated in vitro and allergies (dust mite, endothelium) and PHA. Because children were too young to provide accurate reports, their caregivers were asked how they found their life-threatening and uncontrollable risks. Children whose caregivers rate their life as high for depression have significantly increased cytokine production TNF-α, as well as reduced production of Th-1 cytokine IFN-γ. Importantly, these effects could be present, with the stress that preceded the immune response.

Overall, these studies suggest that among patients with asthma, stress may increase the Th-2 cytokine response to asthma triggers and mitogen cocktails, and in some cases also delay the release of Th-1 cytokines. These latest findings are interesting because Th-1 and Th-2 cytokines often have antagonistic effects on the target and may act in an inhibitory manner. Therefore, a decrease caused by pressure on Th-1 secretion may "allow" greater expression of Th-2 cytokines. Regardless, research shows that humorous improved responses to asthma levels are found in the context of many types of stress, including chronic conditions such as low SES and more severe ones such as school tests, and arise both when stress is considered a need from the environment or the result of a psychological assessment process. Over time, an exaggerated inflammatory response pattern may cause common or severe symptoms of the disease.

Depression makes you more likely to respond to things that often cause asthma - such as pets, pollen or colds, and flu. It can also cause symptoms indirectly. You can easily get angry if you are under pressure, and anger is the result of asthma. For some of us, stress means drinking too much or smoking, both of which put us at risk for asthma symptoms. And if your stress levels are high for a long time, you may find that you often respond to triggering events, and you may have more severe symptoms. In a panic attack, stress hormones are released to prepare us to flee from danger or to fight back (the 'fight or flight' response). We respond to symptoms such as rapid heartbeat, stiff muscles and shortness of breath, and hyperventilating. These changes in our respiratory system can put us at greater risk for all of our common asthma symptoms, such as stiffness and cough.

Asthma was previously thought to be a mental illness due to an episodic condition in which symptoms appeared suddenly without warning or obvious reason. Emotional causes were often thought to lead to an increase in asthma. Numerous clinical studies have found that patients with asthma have higher rates of symptoms of depression and anxiety than healthy controls. Research also suggests that asthma is associated with an increased risk of suicidal thoughts. He conducted a literature search and reviewed eight studies that focused on the increase in depressive symptoms in children and adults with asthma. All eight studies showed that symptoms of depression were more common in children and adults with asthma than in most people. However, only one in eight actually observed the prevalence of major depressive disorder in asthma patients and therefore no conclusions about the degree of systemic emotional disturbance in asthma patients can be made. Eisner studied 743 adults with asthma who were hired after being hospitalized for asthma. They looked at depressive symptoms based on the Center for Epidemiologic Studies Depression Scale and found that these subjects had an 18% prevalence of depressive symptoms. Goodwin found that German adults aged 18 to 65 years and doctors diagnosed present (4 weeks ago) with severe asthma and life-threatening asthma had a significantly higher risk of any anxiety disorder. Mental disorders were assessed using the German National Health Interview and the Examination Survey-Mental Health Supplement (GHS-MHS). The notions of suicide and suicide attempts have been shown to be more common among adults with asthma and this has been independent of a major diagnosis of depression. Depression enhances the intensity of asthma.

It has been difficult to establish a link between asthma and depression. Goodwin suggested that the presence of certain personality traits, such as neuroticism, could explain the association between mental and physical disorders. In a 2006 study, the group investigated the importance of neuroticism in those with allergies and depression. More than 3,000 adults between the ages of 25 and 75 conducted a Midlife Development study in the United States (MIDUS) that included a telephone interview and 2 questionnaires submitted. A detailed retrospective analysis was used to investigate the link between depression and allergies and the role of neuroticism in this relationship. Among their male studies, they found that higher neuroticism was associated with a greater increase in the risk of allergies. After the correction of demographics, depression, and neuroticism, neuroticism became increasingly associated with an increased risk of allergies. For women, there was a significant association between allergies and depression, but this was independent of the effects of neuroticism.

The test posed an antigen challenge to 20 college students with mild asthma during the low-stress and post-traumatic phases. This low-stress phase was performed during the semester or at least 2 weeks after the last test while the depression phase occurred during the last week of testing. The questionnaire is tested for anxiety and depression. Sputum samples were collected prior to the challenge, and 6 hours, 24 hours, and 7 days after the challenge. Sputum eosinophils and eosinophil levels of eosinophils are significantly increased 6 hours and 24 hours after the challenge and are improved during the stress phase. IL-5 generation is also increased in 24 hours during stress and is associated with an increase in sputum eosinophils. Researchers have suggested that stress may act as a cofactor to increase the inflammatory response of the eosinophilic airway to antigen challenge and thus increase the severity of asthma. However, it should be noted that there is no significant decrease in lung function or an increase in reported asthma symptoms associated with these inflammatory changes. Depression management should always be recommended with asthmatics. Smyth investigated adults with mild to moderate asthma and depression and found that asthma sufferers who wrote about their most stressful experiences from the past had improved lung function and decreased levels of stress they reported. The intensity of asthma is increase with the increase in stress and decreases with the decrease in stress. So the students with exams ahead and suffer from asthma, take the stress and level up the intensity of asthma in them.

Evidence suggests higher levels of depression/anxiety and asthma in children, adolescents, and adults alike. Further research is needed to establish the link between these conditions. Further research is needed to determine whether the simultaneous treatment of depression and anxiety in patients with asthma improves the symptoms of asthma. It is equally important that mental health care providers diagnose their patients with mood disorders to detect asthma symptoms such as persistent cough, shortness of breath, or shortness of breath and primary care providers assess their asthma symptoms of depression and/or anxiety. As, during the high pollen count counts, the mood becomes worse and the suicide rate rises we recommend that you pay attention to natural pollen statistics. Therefore, they can identify potential periods of increased risk for compensation and suicide attempts in patients with comorbid intolerance and mood disorders. This is especially important, as allergies to allergens are identified in the brain as a result of allergies and exposure. In addition, Th2 cytokines gene expression was found to increase in the brain of suicide victims compared with controlled studies killed by other causes. Effective imaging studies have identified neuroanatomical substrate interactions between emotion and an increase in asthma signals in the subgenual anterior cingulate cortex and insula. It is important to note that in the subgenual anterior cingulate cortex in patients with severe recurrent depression, a reduction in gray matter has been reported previously, in all episodes of the disease.

Conclusion

Proper diagnosis and treatment of patients with combined asthma and mood disorders are not only important to maintain lung function and respiratory quality of life, but may also adversely affect mood swings if not detected and treated properly. It is equally important for primary care providers and asthma specialists to identify the link between asthma and emotional disorders and assess their patients for depression and anxiety. Patients who show signs of mental illness should be referred to a mental health professional. Complete treatment of patients with psychiatric symptoms due to a medical condition may require a variety of care involving primary care, mental health, and specialist care staff. If underlying depression or anxiety is not considered, this can lead to unnecessary medication changes and screening, inappropriate neutrality, high levels of symptoms, high medical costs, and potentially high mortality.